Sangamo Therapeutics Inc
F:GBY
Sangamo Therapeutics Inc
F:GBY
Price:
0.0662
EUR
Market Closed
Market Cap:
€13.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sangamo Therapeutics Inc
F:GBY
|
US |
|
G
|
Guangshen Railway Co Ltd
XMUN:GRCH
|
CN |
|
C
|
China Everbright Ltd
XMUN:EVI
|
HK |
|
Fathom Nickel Inc
F:6Q5
|
CA |
|
S
|
Seres Therapeutics Inc
F:1S9
|
US |
|
Nfl Biosciences SAS
F:82F
|
FR |
|
M
|
Madison Square Garden Sports Corp
F:MS8
|
US |
|
S
|
Schaeffler AG
DUS:SHA0
|
DE |
|
Tasty PLC
F:T9V
|
UK |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GBY's stock price target?
Not Available
GBY does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Sangamo Therapeutics Inc?
Projected CAGR
90%
90%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 90%.
